These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17873891)

  • 1. Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas.
    Qian ZR; Sano T; Yoshimoto K; Asa SL; Yamada S; Mizusawa N; Kudo E
    Mod Pathol; 2007 Dec; 20(12):1269-77. PubMed ID: 17873891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas.
    Ma HS; Wang EL; Xu WF; Yamada S; Yoshimoto K; Qian ZR; Shi L; Liu LL; Li XH
    Med Sci Monit; 2018 Jul; 24():4841-4850. PubMed ID: 30002361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
    Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
    Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies.
    Xu B; Sano T; Yoshimoto K; Yamada S
    Endocr Pathol; 2002; 13(4):341-51. PubMed ID: 12665652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of RASSF1A tumor suppressor gene by aberrant promoter hypermethylation in human pituitary adenomas.
    Qian ZR; Sano T; Yoshimoto K; Yamada S; Ishizuka A; Mizusawa N; Horiguchi H; Hirokawa M; Asa SL
    Lab Invest; 2005 Apr; 85(4):464-73. PubMed ID: 15711568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas.
    Toyooka S; Toyooka KO; Harada K; Miyajima K; Makarla P; Sathyanarayana UG; Yin J; Sato F; Shivapurkar N; Meltzer SJ; Gazdar AF
    Cancer Res; 2002 Jun; 62(12):3382-6. PubMed ID: 12067979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients.
    Widschwendter A; Ivarsson L; Blassnig A; Müller HM; Fiegl H; Wiedemair A; Müller-Holzner E; Goebel G; Marth C; Widschwendter M
    Int J Cancer; 2004 Mar; 109(2):163-6. PubMed ID: 14750164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of E-cadherin, Slug and NCAM and its relationship to tumor invasiveness in patients with acromegaly.
    Mendes GA; Haag T; Trott G; Rech CGSL; Ferreira NP; Oliveira MC; Kohek MB; Pereira-Lima JFS
    Braz J Med Biol Res; 2017 Dec; 51(2):e6808. PubMed ID: 29267504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
    Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY
    Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation status of the T-cadherin gene promotor in peripheral blood mononuclear cells is associated with HBV-related hepatocellular carcinoma progression.
    Yuan XD; Wang JW; Fang Y; Qian Y; Gao S; Fan YC; Wang K
    Pathol Res Pract; 2020 May; 216(5):152914. PubMed ID: 32147273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene and protein expression of E-cadherin and NCAM markers in non-functioning pituitary adenomas.
    Ongaratti BR; Haag T; D'Ávila MF; Trott G; Ferreira NP; Rech CGSL; Pereira-Lima JFS; da Costa Oliveira M
    Ann Diagn Pathol; 2019 Feb; 38():59-61. PubMed ID: 30419428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced levels of E-cadherin correlate with progression of corticotroph pituitary tumours.
    Evang JA; Berg JP; Casar-Borota O; Lekva T; Kringen MK; Ramm-Pettersen J; Bollerslev J
    Clin Endocrinol (Oxf); 2011 Dec; 75(6):811-8. PubMed ID: 21595730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia.
    Zou D; Yoon HS; Perez D; Weeks RJ; Guilford P; Humar B
    J Pathol; 2009 Jun; 218(2):265-72. PubMed ID: 19294736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCNB1 affects cavernous sinus invasion in pituitary adenomas through the epithelial-mesenchymal transition.
    Li B; Cheng J; Wang H; Zhao S; Zhu H; Li C; Zhang Y; Zhao P
    J Transl Med; 2019 Oct; 17(1):336. PubMed ID: 31585531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of GSTP1 expression by DNA methylation correlates with clinicopathological features in pituitary adenomas.
    Yuan Y; Qian ZR; Sano T; Asa SL; Yamada S; Kagawa N; Kudo E
    Mod Pathol; 2008 Jul; 21(7):856-65. PubMed ID: 18425080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
    Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
    BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear accumulation of e-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomas.
    Elston MS; Gill AJ; Conaglen JV; Clarkson A; Cook RJ; Little NS; Robinson BG; Clifton-Bligh RJ; McDonald KL
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1436-42. PubMed ID: 19158195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 16q genes
    Alkebsi L; Handa H; Yokohama A; Saitoh T; Tsukamoto N; Murakami H
    Oncol Lett; 2016 Nov; 12(5):3523-3530. PubMed ID: 27900031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of E-cadherin expression in breast cancer by promoter hypermethylation and its relation with progression and prognosis of tumor.
    Shargh SA; Sakizli M; Khalaj V; Movafagh A; Yazdi H; Hagigatjou E; Sayad A; Mansouri N; Mortazavi-Tabatabaei SA; Khorram Khorshid HR
    Med Oncol; 2014 Nov; 31(11):250. PubMed ID: 25260805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.